Another COVID-19 Vaccine Candidate Begins Final Clinical Trials - Consumer Health News | HealthDay: TUESDAY, Dec. 29, 2020 (HealthDay News) -- Vaccine maker Novavax, along with federal health researchers, announced Monday that a phase 3 trial will begin on the safety and effectiveness of another COVID-19 vaccine -- the fifth shot to reach this final stage of development. "We've come this far, this...
No comments:
Post a Comment